Cargando…
No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial
BACKGROUND: The objective of this study was to determine whether treatment with the nonselective nonsteroidal anti-inflammatory drug (NSAID) indomethacin slows cognitive decline in patients with Alzheimer's disease (AD). METHODOLOGY/PRINCIPAL FINDINGS: This double-blind, randomized, placebo-con...
Autores principales: | de Jong, Daniëlle, Jansen, René, Hoefnagels, Willibrord, Jellesma-Eggenkamp, Marja, Verbeek, Marcel, Borm, George, Kremer, Berry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194921/ https://www.ncbi.nlm.nih.gov/pubmed/18213383 http://dx.doi.org/10.1371/journal.pone.0001475 |
Ejemplares similares
-
Formulation and evaluation of indomethacin biomicroparticles
por: Gupta, Sudeep, et al.
Publicado: (2012) -
Indomethacin-Induced Hypertensive Crisis
por: Dhungana, Bibek, et al.
Publicado: (2021) -
Tussen wal en schip
por: Jellesma, Gjalt
Publicado: (2020) -
Leve de achtbaan!
por: Jellesma, Gjalt
Publicado: (2020) -
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
por: Summ, Oliver, et al.
Publicado: (2010)